Abstract
We report a rare case of peripheral T-cell lymphoma arising in a 52-year-old man with biopsy-proven aggressive polymyositis, who had cardiac involvement, progressive bulbar symptoms, and died 11 months post diagnosis due to multiorgan failure. Using a multimodality approach including immunohistochemistry, genome-wide single nucleotide polymorphism (SNP)-array analysis, and high-throughput sequencing of the complementary determining region 3 (CDR3) of T-cell receptor beta (TCRβ) genes, our study demonstrates a molecular link between polymyositis and T-cell lymphoma, and provides evidence of the rapid and possibly late occurrence of genomic instability during neoplastic transformation of an oligoclonal T-cell population. Immunohistochemical analysis revealed loss of CD5, CD7, and CD8 antigen expression in autopsy tissue samples, as well as the occurrence of aberrant CD56 expression, not seen in pre-mortem biopsies, supporting the emergence of a neoplastic T-cell population. Multiplex polymerase chain reaction and next-generation sequencing of the TCRβ CDR3 region displayed two unique T-cell clones in both the diagnostic biopsy confirming polymyositis and the autopsy muscle tissue exhibiting T-cell lymphoma, linking the two pathological processes. SNP-array analysis revealed complex genomic abnormalities at autopsy but not in the pre-mortem muscle biopsies displaying polymyositis, confirming malignant transformation of the oligoclonal T-cell infiltrate. Our findings raise the possibility that clinically aggressive polymyositis might represent a preneoplastic condition in some instances, similar to certain other autoimmune and inflammatory disorders.
References
Bender A, Ernst N, Iglesias A, Dornmair K, Wekerle H, Hohlfeld R (1995) T cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8+ T cells. J Exp Med 181(5):1863–1868
Benveniste O, Herson S, Salomon B, Dimitri D, Trebeden-Negre H, Jean L, Bon-Durand V, Antonelli D, Klatzmann D, Boyer O (2004) Long-term persistence of clonally expanded T cells in patients with polymyositis. Ann Neurol 56(6):867–872. doi:10.1002/ana.20293
Buchbinder R, Forbes A, Hall S, Dennett X, Giles G (2001) Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 134(12):1087–1095
Chan KK, Shen L, Au WY, Yuen HF, Wong KY, Guo T, Wong ML, Shimizu N, Tsuchiyama J, Kwong YL, Liang RH, Srivastava G (2010) Interleukin-2 induces NF-kappaB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells. J Pathol 221(2):164–174. doi:10.1002/path.2699
Crinquette C, De Seze J, Maurage CA, Launay D, Ferriby D, Delalande S, Hachulla E, Stojkovic T, Vermersch P (2007) Polymyositis and cranial neuropathy. Rev Neurol (Paris) 163(11):1075–1081
Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362(9388):971–982. doi:10.1016/S0140-6736(03)14368-1
Endo T, Kawaguchi N, Yashima M, Tei H, Hayakawa H (1993) Polymyositis-dermatomyositis and non-Hodgkin’s lymphoma. Intern Med 32(6):487–489
Hatachi S, Kunitomi A, Aozasa K, Yagita M (2010) CD8(+) T-cell lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis during methotrexate therapy. Mod Rheumatol 20(5):500–505. doi:10.1007/s10165-010-0300-z
Kamstrup MR, Gjerdrum LM, Biskup E, Lauenborg BT, Ralfkiaer E, Woetmann A, Odum N, Gniadecki R (2010) Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma. Blood 116(14):2504–2512. doi:10.1182/blood-2009-12-260216
Khan S, Christopher-Stine L (2011) Polymyositis, dermatomyositis, and autoimmune necrotizing myopathy: clinical features. Rheum Dis Clin North Am 37(2):143–158. doi:10.1016/j.rdc.2011.01.001
Lundberg IE (2006) The heart in dermatomyositis and polymyositis. Rheumatology (Oxford) 45(Suppl 4):18–21. doi:10.1093/rheumatology/kel311
Mantegazza R, Andreetta F, Bernasconi P, Baggi F, Oksenberg JR, Simoncini O, Mora M, Cornelio F, Steinman L (1993) Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. Restricted V alpha/beta rearrangements may indicate antigen-driven selection. J Clin Invest 91(6):2880–2886. doi:10.1172/JCI116533
Marie I, Guillevin L, Menard JF, Hatron PY, Cherin P, Amoura Z, Cacoub P, Bachelez H, Buzyn A, Le Roux G, Ziza JM, Brice P, Munck JN, Sarrot-Reynauld F, Piette JC, Larroche C (2011) Hematological malignancy associated with polymyositis and dermatomyositis. Autoimmun Rev doi:10.1016/j.autrev.2011.10.024
Neravanda D, Kent M, Platt SR, Gruenenfelder FI, Shelton GD, Schatzberg SJ (2009) Lymphoma-associated polymyositis in dogs. J Vet Intern Med 23(6):1293–1298. doi:10.1111/j.1939-1676.2009.0391.x
Nishio J, Suzuki M, Miyasaka N, Kohsaka H (2001) Clonal biases of peripheral CD8 T cell repertoire directly reflect local inflammation in polymyositis. J Immunol 167(7):4051–4058
O’Hanlon TP, Dalakas MC, Plotz PH, Miller FW (1994) Predominant TCR-alpha beta variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies. J Immunol 152(5):2569–2576
Odabasi Z, Parrott JH, Reddy VV, Oh SJ (2001) Neurolymphomatosis associated with muscle and cerebral involvement caused by natural killer cell lymphoma: a case report and review of literature. J Peripher Nerv Syst 6(4):197–203
Sigurgeirsson B, Lindelof B, Edhag O, Allander E (1992) Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 326(6):363–367. doi:10.1056/NEJM199202063260602
Tsunemine H, Maruoka H, Akasaka H, Udaka K, Yamamoto K, Ishikawa Sakane E, Hiramoto N, Ito K, Kodaka T, Itoh T, Takahashi T (2013) Polymyositis as a paraneoplastic syndrome in cytotoxic molecule-positive and Epstein-Barr virus-associated peripheral T-cell lymphoma, not otherwise specified. Intern Med 52(8):901–905
van de Water JM, Cillessen SA, Visser OJ, Verbeek WH, Meijer CJ, Mulder CJ (2010) Enteropathy associated T-cell lymphoma and its precursor lesions. Best Pract Res Clin Gastroenterol 24(1):43–56. doi:10.1016/j.bpg.2009.11.002
Zampieri S, Valente M, Adami N, Biral D, Ghirardello A, Rampudda ME, Vecchiato M, Sarzo G, Corbianco S, Kern H, Carraro U, Bassetto F, Merigliano S, Doria A (2010) Polymyositis, dermatomyositis and malignancy: a further intriguing link. Autoimmun Rev 9(6):449–453. doi:10.1016/j.autrev.2009.12.005
Zhang R, Shah MV, Loughran TP Jr (2010) The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders. Hematol Oncol 28(3):105–117. doi:10.1002/hon.917
Zhao WL (2010) Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathways. Leukemia 24(1):13–21. doi:10.1038/leu.2009.223
Acknowledgments
We thank Dr. James Goldman and Dr. Jean Paul Vonsattel for their helpful critique of the manuscript and David Hamm from Adaptive Biotechnology Corp. for help with analysis of the TCRβ deep sequencing data.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
G. Bhagat and K. Tanji contributed equally/co-senior authors.
Rights and permissions
About this article
Cite this article
Tsankova, N.M., Bevan, C., Jobanputra, V. et al. Peripheral T-cell lymphoma emerging in a patient with aggressive polymyositis: molecular evidence for neoplastic transformation of an oligoclonal T-cell infiltrate. Acta Neuropathol 126, 595–601 (2013). https://doi.org/10.1007/s00401-013-1164-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-013-1164-z